查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1302892

花生四烯酸市场——2023年至2028年预测

Arachidonic Acid Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 130 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计在预测期内，全球花生四烯酸市场将以 5.15% 的复合年增长率增长。

花生四烯酸是一种有助于婴儿大脑发育的脂肪酸。花生四烯酸 (ARA) 是生物细胞膜的重要组成部分，为所有细胞提供正常运作所需的流动性和灵活性，尤其是免疫系统、骨骼肌和神经系统中的细胞。亚油酸来源于食物或亚油酸通过去饱和和链伸长而得。离子通道、受体和□都受到游离 ARA 激活和抑制能力的影响。

重要的 omega-6 脂肪酸之一是花生四烯酸。它被认为是一种必需酸，因为它保留在细胞膜内，并发出响应破坏事件的再生变化信号。由于体内缺乏天然花生四烯酸，花生四烯酸必须通过注射剂、糖浆和片剂单独服用。ARA的主要原料是玉米、葡萄糖、大豆、酵母。

随着消费者健康意识的增强，营养补充剂中对 ARA 的需求不断增加。随着赛车和马拉松等户外运动赛事越来越受欢迎，身体受伤的可能性预计会增加，并预计将推动市场覆盖率和创收的上升。婴儿配方奶粉的普及率不断上升，运动营养品的使用频率也不断增加，有助于市场扩张。

增加婴儿配方奶粉中花生四烯酸的使用

由于技术的快速进步和领先公司的新专利申请，在预测期内，婴儿配方奶粉中花生四烯酸的使用可能会增加。婴儿需要 omega-6 脂肪酸，因为他们无法合成所需的量。因此，在婴儿食品中添加ARA起到了供给必需脂肪酸的作用。帮助发育中的婴儿大脑合成细胞膜的主要成分是 DHA 和花生四烯酸 (ARA)（一种 20 碳脂肪酸）。母乳中 DHA 和 ARA 的含量因国家而异，具体取决于母亲的饮食。

田径运动是 ARA 需求量很大的一个重要领域。

花生四烯酸在田径界正在蓬勃发展。ARA 补充剂也在神经病学、肝病学、心脏病学和营养学领域进行研究。儘管花生四烯酸可以控制炎症，但人们仍担心这些补充剂的相关风险。受过训练的男性的瘦体重指数、全身力量和峰值功率都可以通过 ARA 补充剂得到改善。

富含 ARA 的油的供应是一个重要的需求驱动因素。

从真菌高山被孢霉中提取的富含 ARA 的油的使用是众所周知的，这种成分长期以来一直用于婴儿配方奶粉和后续牛奶中。根据欧盟法律，从高山被孢霉中提取的油目前被允许用于婴儿配方奶粉、后续牛奶和新生儿医疗饮食。德国BASF和中国Hubei Fuxing Biotechnology是利用高山被Mortierella Alpina菌生产富含 ARA 的油的领先公司。

预计北美将成为预测期内的主要市场。

预计北美将成为花生四烯酸在食品应用中的最大市场，其次是欧洲和亚太地区。欧盟监管环境支持本地市场的扩张。婴儿配方奶粉中 ARA 的需求受到众多公司的存在、积极的研发活动以及在婴儿配方奶粉和运动营养中使用 ARA 的大量新专利以及北美（尤其是墨西哥）出生率不断上升的推动。目前利用 ARA 治疗糖尿病的趋势预计将支持北美国家市场的进一步扩张。

市场趋势：

  • 2022年10月，CABIO研发中心投资项目在武汉光谷启动。基于上述投资举措，与CABIO Biotech（武汉）、Hubei Yangtze Science Innovation Service合作启动了武汉合成生物创新中心项目。
  • 2022 年 7 月，Continental Grain和Cargill收购了Sanderson Farm。作为交易的一部分，两家公司合併了Sanderson Farm和Wayne Farm，创建了一家新的家禽公司。

目录

第 1 章 简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场细分
  • 货币
  • 先决条件
  • 基准年和预测年的时间表

第二章研究方法论

  • 调查数据
  • 先决条件

第三章执行摘要

  • 调查亮点

第四章市场动态

  • 市场驱动力
  • 市场製约因素
  • 波特五力分析
  • 行业价值链分析

第五章全球花生四烯酸市场：按来源分类

  • 介绍
  • 动物
  • 植物

6.全球花生四烯酸市场，按形式

  • 介绍
  • 烘干
  • 液体

第七章全球花生四烯酸市场：按应用分类

  • 介绍
  • 食品与饮品
    • 婴幼儿配方奶粉
    • 膳食补充剂
  • 药品

第八章全球花生四烯酸市场：按地区

  • 介绍
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 其他
  • 中东/非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 其他
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印度尼西亚
    • 泰国
    • 其他

第九章竞争格局与分析

  • 主要公司及战略分析
  • 初创企业和市场盈利能力
  • 合併、收购、协议与合作
  • 供应商竞争力矩阵

第十章公司简介

  • Cargill. Inc
  • Cabio Biotech（Wuhan）Co., Ltd
  • Cayman Chemicals
  • Koninklijke DSM N.V.
  • Merck Group
  • Suntory Beverage & Food Ltd.
  • Cayman Chemical Company
  • Avanti Polar Lipids, Inc.
简介目录
Product Code: KSI061615437

The global arachidonic acid market is estimated to grow at a CAGR of 5.15% during the forecast period.

Arachidonic is a fatty acid that helps in a baby's developing brain. Arachidonic acid (ARA) is a crucial aspect of biological cell membranes because it gives them the fluidity and flexibility necessary for all cells to function properly, especially those in the immune system, skeletal muscle, and neurological systems. It comes from food or linoleic acid undergoing de-saturation and chain elongation. Ion channels, receptors, and enzymes are all affected by free ARA's ability to both activate and inhibit them.

One of the important Omega-6 fatty acids is arachidonic acid. It is regarded as an essential acid. because it is kept inside cell membranes and guides signals of regenerative changes in response to damaging events. A separate intake of arachidonic acid in injections, syrups, or pills is required due to the body's lack of natural arachidonic acid. The main ingredients used to make ARA are, among others, maize, glucose, soy, and yeast.

There is a rising demand for ARA in dietary supplements as consumers become more health conscious. The probability of physical injuries is anticipated to rise with the popularity of outdoor athletic events like car racing and marathons, which are projected to drive the market in terms of rising application rates and generating revenue. Infant feeding formula penetration is rising, and sports nutrition is also being used more frequently, contributing to the market's expansion.

Increased use of arachidonic acid in infant formula

The fast technical improvements and new patents filed by the major market players will likely lead to a rise in the use of arachidonic acid in baby feeding during the forecast period. Babies require omega-6 fatty acids since they cannot synthesize the necessary quantity. As a result, the inclusion of ARA in baby food serves to supply the required fatty acids. The main elements that aid in synthesizing cell membranes in developing infants' brains are DHA and arachidonic acid (ARA), a 20-carbon fatty acid. Depending on a mother's diet, the amount of DHA and ARA in breast milk varies greatly between nations.

Athletics is a key area for the growing demand for ARA.

Arachidonic acid is growing rapidly in the world of athletics. Research on ARA supplements has also been conducted in neurology, hepatology, cardiology, and nutrition. Arachidonic acid regulates inflammation, although there are concerns regarding the risks associated with these supplements. The lean BMI, overall strength, and peak power of trained men may all be improved with ARA supplementation.

Utilization of ARA-rich oils is a significant demand driver.

The use of ARA-rich oils obtained from the fungus Mortierella Alpina is well known, and the ingredient has long been used in infants and subsequent formulae. According to EU law, oil extracted from Mortierella Alpina is now allowed in infant formula, follow-on formula, and meals for medical purposes for newborns. The German company BASF and the Chinese company Hubei Fuxing Biotechnology are the leading firms producing ARA-rich oils from the fungus Mortierella Alpina.

North America is projected to be the prominent market throughout the forecast period.

North America is anticipated to be the largest market for arachidonic acid in food applications, second in Europe and Asia Pacific. The regulatory environment in the EU has helped the local market expand. The demand for ARA in infant formula is growing due to the presence of numerous companies, the intense R&D activities carried out with numerous new patents using ARA for infant formula, as well as sports nutrition, and the rising fertility rate in North America, particularly in Mexico. The current trend of utilizing ARA to treat diabetes is anticipated to aid in expanding the market in additional North American nations.

Market Developments:

  • In October 2022, the CABIO R&D Centre investment project started in Wuhan Optical Valley. The Wuhan Synthetic Biology Innovation Centre project was launched based on the aforementioned investment initiative, a collaboration between CABIO Biotech (Wuhan) and Hubei Yangtze Science Innovation Service.
  • In July 2022, Continental Grain and Cargill bought Sanderson Farms. Both have merged Sanderson Farms and Wayne Farms as part of the transaction to launch a new chicken company.

Market Segmentation:

By Source

  • Animal
  • Plant

By Form

  • Dry
  • Liquid

By Application

  • Food and Beverage
  • Infant Formula
  • Dietary Supplements
  • Pharmaceuticals

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. GLOBAL ARACHIDONIC ACID MARKET, BY SOURCE

  • 5.1. Introduction
  • 5.2. Animal
  • 5.3. Plant

6. GLOBAL ARACHIDONIC ACID MARKET, BY FORM

  • 6.1. Introduction
  • 6.2. Dry
  • 6.3. Liquid

7. GLOBAL ARACHIDONIC ACID MARKET, BY APPLICATION

  • 7.1. Introduction
  • 7.2. Food and Beverage
    • 7.2.1. Infant Formula
    • 7.2.2. Dietary Supplements
  • 7.3. Pharmaceuticals

8. GLOBAL ARACHIDONIC ACID MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

  • 10.1. Cargill. Inc
  • 10.2. Cabio Biotech (Wuhan)Co., Ltd
  • 10.3. Cayman Chemicals
  • 10.4. Koninklijke DSM N.V.
  • 10.5. Merck Group
  • 10.6. Suntory Beverage & Food Ltd.
  • 10.7. Cayman Chemical Company
  • 10.8. Avanti Polar Lipids, Inc.